Sudarshan Chemical Industries Limited has informed the Exchange about Presentation
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical shared its Q3 FY26 investor presentation, reporting One Sudarshan (combined entity) revenue of ₹2,387 Cr, with consolidated Adjusted EBITDA of just ₹40 Cr (1.9% margin), though this was an improvement from -₹38 Cr in Q2 FY26. The Acquired Group (Heubach) remained in the red with an EBITDA loss of -₹38 Cr in Q3, down from -₹116 Cr in Q2, hurt by weak demand, destocking and tariffs. Legacy Sudarshan held up better with ₹77 Cr EBITDA at 11.8% margin (vs ₹79 Cr in Q3 FY25). The company revised its FY26 Business EBITDA outlook for the Acquired Group downward to ~€16 Mn from earlier ~€25 Mn, while guiding Q4 FY26 EBITDA of ~€9-10 Mn. Net debt stood at ₹1,123 Cr and management targets €30-40 Mn of finished goods inventory reduction over the next three quarters to ease working capital.
Negative for near-term sentiment — FY26 EBITDA guidance for the acquired Heubach business was cut sharply (~36% lower), confirming margin pressure and a slower-than-expected integration turnaround. However, sequential improvement in the Acquired Group's losses, easing destocking, and a long-term target of €90-100 Mn EBITDA by FY28/29 provide some medium-term hope for recovery.